The enhanced expression of the cyclin D/CDK4/Rb pathway inevitably contributed to the rampant survival and proliferation of cancer cells within a large variety of malignant categories, especially osteosarcoma [13] and synovial sarcoma [14]. The gene discussed is RB1; the disease is cancer.